4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-024525
Options or other derivatives
- Director acquired 19,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Haviland Kate Director | 2022-06-27 | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…